CHI3L1 and liver disorder: In clinical applications, studies have shown that CHI3L1 levels were significantly elevated in liver diseases and increased with the severity of the disease [5, 7], which was also emphasized in the “Guidelines on the Management of Hepatic Encephalopathy in Cirrhosis” [8].